BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 9924144)

  • 21. The pivotal role of VEGF in tumor angiogenesis: molecular facts and therapeutic opportunities.
    Siemeister G; Martiny-Baron G; Marmé D
    Cancer Metastasis Rev; 1998 Jun; 17(2):241-8. PubMed ID: 9770121
    [No Abstract]   [Full Text] [Related]  

  • 22. Molecular basis of angiogenesis. Role of VEGF and VE-cadherin.
    Carmeliet P; Collen D
    Ann N Y Acad Sci; 2000 May; 902():249-62; discussion 262-4. PubMed ID: 10865845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure and function of vascular endothelial growth factor receptor-1 and -2.
    Shibuya M; Ito N; Claesson-Welsh L
    Curr Top Microbiol Immunol; 1999; 237():59-83. PubMed ID: 9893346
    [No Abstract]   [Full Text] [Related]  

  • 24. VEGFs, receptors and angiogenesis.
    Veikkola T; Alitalo K
    Semin Cancer Biol; 1999 Jun; 9(3):211-20. PubMed ID: 10343072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular endothelial growth factor: basic biology and clinical implications.
    Ferrara N; Keyt B
    EXS; 1997; 79():209-32. PubMed ID: 9002234
    [No Abstract]   [Full Text] [Related]  

  • 26. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular endothelial growth factor and the regulation of angiogenesis.
    Ferrara N
    Recent Prog Horm Res; 2000; 55():15-35; discussion 35-6. PubMed ID: 11036931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of vascular endothelial growth factor in the regulation of angiogenesis.
    Ferrara N
    Kidney Int; 1999 Sep; 56(3):794-814. PubMed ID: 10469350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiogenesis in embryos and ischemic diseases.
    Breier G; Damert A; Plate KH; Risau W
    Thromb Haemost; 1997 Jul; 78(1):678-83. PubMed ID: 9198238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. VEGF receptor signaling in tumor angiogenesis.
    McMahon G
    Oncologist; 2000; 5 Suppl 1():3-10. PubMed ID: 10804084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-1alpha promotes angiogenesis in vivo via VEGFR-2 pathway by inducing inflammatory cell VEGF synthesis and secretion.
    Salven P; Hattori K; Heissig B; Rafii S
    FASEB J; 2002 Sep; 16(11):1471-3. PubMed ID: 12205052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular endothelial growth factor (VEGF) and its effect on angiogenesis.
    Jośko J; Gwóźdź B; Jedrzejowska-Szypułka H; Hendryk S
    Med Sci Monit; 2000; 6(5):1047-52. PubMed ID: 11208453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of vascular endothelial growth factor and vascular endothelial growth factor receptors in vascular development.
    Carmeliet P; Collen D
    Curr Top Microbiol Immunol; 1999; 237():133-58. PubMed ID: 9893349
    [No Abstract]   [Full Text] [Related]  

  • 34. Functions of the VEGF/VEGF receptor system in the vascular system.
    Breier G
    Semin Thromb Hemost; 2000; 26(5):553-9. PubMed ID: 11129412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular biology of the VEGF and the VEGF receptor family.
    Clauss M
    Semin Thromb Hemost; 2000; 26(5):561-9. PubMed ID: 11129413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation and action of angiogenic factors in the primate ovary.
    Stouffer RL; Martínez-Chequer JC; Molskness TA; Xu F; Hazzard TM
    Arch Med Res; 2001; 32(6):567-75. PubMed ID: 11750732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphatic versus blood vascular endothelial growth factors and receptors in humans.
    Partanen TA; Paavonen K
    Microsc Res Tech; 2001 Oct; 55(2):108-21. PubMed ID: 11596156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulations of vasculatropin/vascular endothelial growth factor bioavailability.
    Plouët J; Bayard F
    Horm Res; 1994; 42(1-2):14-9. PubMed ID: 7959629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. VEGF-mediated tumour angiogenesis: a new target for cancer therapy.
    Martiny-Baron G; Marmé D
    Curr Opin Biotechnol; 1995 Dec; 6(6):675-80. PubMed ID: 8527839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular endothelial growth factor.
    Zachary I
    Int J Biochem Cell Biol; 1998 Nov; 30(11):1169-74. PubMed ID: 9839443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.